Salt Lake City, UT, United States of America

Olga Matveeva


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Olga Matveeva

Introduction

Olga Matveeva is a prominent inventor based in Salt Lake City, Utah. She has made significant contributions to the field of antisense oligonucleotides, with a focus on methods for obtaining active compounds. Her work has led to the development of innovative techniques that enhance the effectiveness of antisense oligonucleotides.

Latest Patents

Olga Matveeva holds two patents related to her research. The first patent outlines methods for obtaining antisense oligonucleotides with activity against a desired target. It includes methods for identifying oligonucleotide sequence motifs that predict antisense oligonucleotide activity. Additionally, it provides techniques for selecting effective antisense oligonucleotide sequences and target sequences. The second patent reiterates these methods, emphasizing the design of oligonucleotides that hybridize to target sequences containing activity-enhancing motifs. Antisense oligonucleotides designed according to these methods are also included.

Career Highlights

Throughout her career, Olga has worked with notable organizations such as Isis Pharmaceuticals, Inc. and the University of Utah Research Foundation. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Olga Matveeva has collaborated with esteemed colleagues, including Susan M. Freier and Alexander Tsodikov. These collaborations have further enriched her research and innovation in the field of antisense oligonucleotides.

Conclusion

Olga Matveeva's work in the development of antisense oligonucleotides showcases her innovative spirit and dedication to advancing scientific knowledge. Her patents and career achievements reflect her significant impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…